Noticias y Actividades de Marinus Pharmaceuticals

Marinus Pharmaceuticals es una de las ...

• Russell 3000;
• TOB Iconic 10,000.

Marinus Pharmaceuticals es una empresa que cotiza bajo el símbolo de cotización MRNS (US).

Ver el organigrama con sus 16 ejecutivos principales

Biografías más buscadas en Marinus Pharmaceuticals

• Scott Braunstein, Chief Executive Officer and Chairman of the Board
• Seth Fischer, Director
• Elan Ezickson, Director

Crear su alerta
para seguir los movimientos de los ejecutivos en Marinus Pharmaceuticals.

Marinus Pharmaceuticals tiene 1.826 competidores entre los que se incluyen Pfizer (Estados Unidos), Sanofi (Francia) y Roche (Suiza).

Popular M&A news in Farmacia

• Cyclo Therapeutics ha Rafael Holdings adquirido (publicado el 28 de abril de 2025).
• Chimerix and Chimerix have merged  (publicado el 22 de abril de 2025)..
• Imbria Pharmaceuticals acaba de anunciar una recaudación de fondos de 58 millones de dólares. (publicado el 10 de abril de 2025).

Otros contactos sugeridos en el sector Farmacia

• Estelle Vester-Blokland - Senior Vice President, Medical and Head, International Markets en Bristol-Myers Squibb
• Seth Harrison - Chairman and Director en Braeburn Pharmaceuticals
• Jean-Michel Demeure - Vice President, Finance Global Operations en Sanofi

Saber más sobre el sector Farmacia

Últimos comunicados de prensa de Marinus Pharmaceuticals

• Immedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc.
• Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2024 Financial Results
• Marinus Pharmaceuticals Announces Topline Results From Phase 3 TrustTSC Trial of Oral Ganaxolone in Tuberous Sclerosis Complex and Commences Process to Explore Strategic Alternatives
• Marinus Pharmaceuticals Further Strengthens Intellectual Property Estate with Method of Treatment Patent for ZTALMY® Titration Regimens
• Marinus Pharmaceuticals Presents Clinical Data From Pivotal Phase 3 RAISE Trial in Refractory Status Epilepticus at the Neurocritical Care Society 2024 Annual Meeting
• Marinus Pharmaceuticals Announces Podium and Poster Presentations at the Neurocritical Care Society 2024 Annual Meeting
• Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
• Marinus Pharmaceuticals to Highlight Clinical Progress and Commercial Launch Preparedness for ZTALMY® in TSC at Investor and Analyst Day
• Marinus Pharmaceuticals Announces Agenda and Speakers for Investor & Analyst Day on September 20, 2024
• Marinus Pharmaceuticals to Present at the 2024 Cantor Global Healthcare Conference
• View more press releases Close

Redes sociales sobre Marinus Pharmaceuticals

• Marinus Pharmaceuticals en Wikipedia, Google News y Yahoo Finance
• Marinus Pharmaceuticals en LinkedIn, Twitter y YouTube